Concepedia

Elvia Medina-Paraiso

EM

Statistics

Publications

1

Citations

20

H-Index

1

Active since

2017

Affiliations

Mitsubishi Tanabe Pharma Corporation(Current)

Elvia Medina-Paraiso is an author at Mitsubishi Tanabe Pharma Corporation.

Publications per year

2017–2017

1

Publications

1

A safety analysis of edaravone (MCI-186) during the first six cycles (24 weeks) of amyotrophic lateral sclerosis (ALS) therapy from the double-blind period in three randomized, placebo-controlled studies

Alexander Kalin, Elvia Medina-Paraiso, Kaoru Ishizaki et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 2017 · 20 citations · Full text

1–1 of 1